Member Info for Hypermarlin

Twatcher, as you said it would be nice if indeed "the guardian would instantaneously combust."

Not enough ex-shareholders willing to come back to create a SNG moment, I would think. The last few days will have had many run for the hills and take a nasty loss; and not enough new investors as there is no new story, really. Just some traders right now, I would expect, but they'll be gone soon.

Anyone know why SSTY has gone up so much today? I see no news, other than a 2021 better story, maybe, but that's a long way off.

@Chuggley, agree. However, CK and his buddies have their hand very very full at the moment and I seriously doubt they could carve out the time from what I assume are very long days to craft such a presentation. If it was not perfect, and might be presented, shall we say, somewhat dourly, then it's going to have the opposite effect on confidence. ODX needs a commercial director, head of sales, someone that can punch this stuff out. I don't think they do have such a person. Interesting to note that only a couple of months ago they added a Global Marketing Dtr https://www.linkedin.com/in/alisonmthompson/ we'll have to see if she can light up the comms a bit; I have to say looking at her prior career in LinkedIn, they've not chosen a seasoned marketeer, but a scientist with a Chartered Institute of Marketing qualification. Oh dear... Here's their Global Sales Director, https://www.linkedin.com/in/thomas-cookson-b9b19039/, can't even be bothered to add his picture to LinkedIn. Oh dear....

If this is it https://www.theguardian.com/world/2020/nov/13/covid-test-for-mass-uk-screening-could-miss-up-to-half-of-cases-say-scientists, same gist. They are hammering the gov't, as they would, it's the Guardian.

@Symbo1 - excellent summary.

Can someone post Colin's email address please? I have some constructive comments I would like to offer him, not cc Paul @ Walbrook. About marketing as well as investor relations.

@kfordearp - very cool. Thanks.

@kfordearp - may I ask how did you find that date? Undated websites/blogs/opinion pieces drive me crazy.

If you put the hyperlink in " " and search in Google, you will find a cached version dated 7 Nov 2020 15:23:54 GMT, so that might be it's first appearance.

Don't forget all the spin about DIY testing whilst brishung teeth/putting the kettle on. Whilst those statements (in the context of moonshot) likely applied to antigen testing, the spin has been applied here too.

@Symbo1 - I fear there may be no approval, for home use. The product of the UK RTC may well be restricted to professional use only, given this debacle. Hopefully the consortium can overcome this somehow.

Buying frenzy? You must be on the giggle juice, don't put it in your cornflakes next time.

@Ozaz - get a grip, that's antigen testing, this hoo har this morning is Antibody testing.

@Regulator - "The contracts awarded to the UK-RTC are the subject of legal proceedings - there's an application for judicial review in play". I completely missed this. Since when? Who's suing who? (if that's what it is?). Thanks!

@Regulator, sure, but that's the government you are talking about, right? All will be OK then! Not.

@Stevie - agreed. Unreal management, sorry CK, I'm losing the faith. Been here so, so many months.

Get with the pace, bedwetters, and sit on your hands. ODX is contracted to supply whatever the RTC orders. The Guardian's article has nothing to do with ODX, that ODX can talk about in the market. They can't issue a negative speeding ticket "we know of no reason for the SP decline" because it's obvious what the reason is. If you invested in ODX expecting an instant return, it's the wrong share. I did, but I've come to appreciate that a quick return is not going to happen, this is long term now. So be it.

Hope we don't have to wait the full 12 months of this loan duration before East Imperial is wrapped up!

UK bought gzillions of Ab tests, months ago, Roche and Abbot.